|
|
Volumn 11, Issue 9, 1998, Pages 523-569
|
|
Glutamate in CNS disorders as a target for drug development: An update
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALCOHOL;
ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID;
AMPA RECEPTOR;
CALCIUM ION;
CARRIER PROTEIN;
COCAINE;
CONCANAVALIN A;
CYCLOTHIAZIDE;
DIZOCILPINE;
GLUTAMATE RECEPTOR;
GLUTAMIC ACID;
GLYCINE;
GLYCINE RECEPTOR;
GLYCINE RECEPTOR AGONIST;
GLYCINE RECEPTOR ANTAGONIST;
GLYCOPROTEIN GP 120;
HISTAMINE;
IFENPRODIL;
KAINIC ACID RECEPTOR;
KYNURENIC ACID;
N ACETYLASPARTYLGLUTAMIC ACID;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;
OPIATE;
POLYAMINE DERIVATIVE;
SPERMIDINE;
SPERMINE;
TRANSACTIVATOR PROTEIN;
UNINDEXED DRUG;
ALZHEIMER DISEASE;
BRAIN INJURY;
BRAIN METABOLISM;
CHRONIC PAIN;
DEPRESSION;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
DRUG RESEARCH;
DRUG SCREENING;
EPILEPSY;
HUMAN;
NEUROMODULATION;
NEUROTOXICITY;
NONHUMAN;
PATHOPHYSIOLOGY;
RECEPTOR AFFINITY;
REVIEW;
SCHIZOPHRENIA;
STROKE;
|
|
EID: 0032467053
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.1998.11.9.863689 Document Type: Review |
|
Times cited : (404)
|
|
References (783)
|
